Sensus Healthcare (SRTS) EBITDA Margin (2016 - 2025)
Sensus Healthcare's (SRTS) quarterly EBITDA Margin came in at 63.74% in Q4 2025, down 7695.0% year-on-year from 0.84% in Q4 2024, and down 70.79% quarter-over-quarter from 37.32% in Q3 2025.
Sensus Healthcare (SRTS) EBITDA Margin (2016 - 2025) Analysis & Trends
Sensus Healthcare's EBITDA Margin history runs 10 years deep, the most recent figure standing at 63.74% for Q4 2025.
- On a quarterly basis, EBITDA Margin fell 7695.0% year-over-year to 63.74% in Q4 2025; TTM through Dec 2025 was 37.5%, a 5685.0% decrease from a year earlier, with the FY2025 full-year figure at 37.5%, down 5686.0% from the prior year.
- EBITDA Margin fell to 63.74% in Q4 2025 per SRTS's latest filing, from 37.32% in the prior quarter.
- Across five years, EBITDA Margin topped out at 44.38% in Q4 2023 and bottomed at 86.09% in Q1 2023.
- The 5-year median for EBITDA Margin is 8.37% (2021), against an average of 3.07%.
- Across the five-year window, EBITDA Margin jumped 21244 bps in 2021 and plunged 12410 bps in 2023, its largest moves.
- Year by year, EBITDA Margin stood at 40.84% in 2021, then dropped by 22 bps to 31.84% in 2022, then jumped by 39 bps to 44.38% in 2023, then tumbled by 70 bps to 13.21% in 2024, then slumped by 583 bps to 63.74% in 2025.
- Per Business Quant, the three latest SRTS EBITDA Margin figures stand at 63.74% (Q4 2025), 37.32% (Q3 2025), and 26.56% (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 28.97% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 21.42% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 6.17% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.04% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Sensus Healthcare | 50.14 Mn | 31.81 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -63.74% |
| Sep 30, 2025 | -37.32% |
| Jun 30, 2025 | -26.56% |
| Mar 31, 2025 | -31.71% |
| Dec 31, 2024 | 13.21% |
| Sep 30, 2024 | 16.91% |
| Jun 30, 2024 | 21.45% |
| Mar 31, 2024 | 27.07% |
| Dec 31, 2023 | 44.38% |
| Sep 30, 2023 | -48.61% |
| Jun 30, 2023 | -24.90% |
| Mar 31, 2023 | -86.09% |
| Dec 31, 2022 | 31.84% |
| Sep 30, 2022 | 23.98% |
| Jun 30, 2022 | 37.83% |
| Mar 31, 2022 | 38.02% |
| Dec 31, 2021 | 40.84% |
| Sep 30, 2021 | 3.53% |
| Jun 30, 2021 | -5.15% |
| Mar 31, 2021 | -36.32% |